# Cytarabine

NDC: 68083-337
Generic name: Cytarabine
Labeler / Manufacturer: Gland Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20191223

FDA application: ANDA211938

## Active ingredients

- CYTARABINE: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68083-337"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68083-337
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb0db038-4a65-42c7-aa79-5c88309061df